Pluvicto
Ended Awarded Last action
- Contract number
- 36C25025N0019
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $896,106
Award facts
- Contract value 100% obligated
- $896,106.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$166,146 | |
| Supplemental Agreement for work within scope | -$659,421 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,721,673 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $896,106.33 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Department of Veterans Affairs' Veterans Integrated Service Network 10 on October 1, 2024. The contract, which is not set-aside for small businesses, covers the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), an advanced nuclear medicine product used for targeted radioligand therapy and cancer treatment. Performance will be completed by September 30, 2025, with work conducted at the contractor's facility in East Hanover, New Jersey. This award represents a delivery order against the company's existing GSA Schedule contract under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
This contract reflects the VA's ongoing procurement of specialized radiopharmaceutical products through established vendor relationships to support nuclear medicine diagnostic and therapeutic capabilities across its healthcare system. Advanced Accelerator Applications USA Inc. maintains a substantial federal contract portfolio with the VA and other agencies including the Defense Health Agency and National Institutes of Health, with multiple BPAs and indefinite delivery vehicles facilitating the efficient ordering of critical nuclear medicine products for federal medical centers and facilities.
Quick answers
Who was awarded contract 36C25025N0019?
36C25025N0019 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C25025N0019 worth?
The government has obligated $896,106 on 36C25025N0019.
Is contract 36C25025N0019 an order under another contract?
Yes. 36C25025N0019 is a BPA call under 36F79719D0169-36C25023A0020, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25025N0019 competed?
The extent of competition for 36C25025N0019 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award